Royal Bank of Canada »

Avenue Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Avenue Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avenue Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avenue Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 514 0.00
2023-09-30 $0 98 0.00
2023-06-30 $0 52 0.00
2022-12-31 $0 55 0.00